Preceptis Medical
Preceptis Medical designs and provides ear tube systems and related medical instruments across the U.S.
- 32
- Private company
- Golden Valley, MN, USUnited States
Preceptis Medical designs and provides ear tube systems and related medical instruments across the U.S.
hummingbirdeartubes.comCrawled Oct 21, 2026
The new CMS code supports Hummingbird ear tubes, which have proven clinical results for safer in-office pediatric care.
Bring efficiency and clarity to pediatric ear care. Hummingbird TTS brings anesthesia-free options for families seeking alternatives to traditional ear tube surgery.
The Hummingbird is an FDA-cleared alternative for less invasive ear tube procedures without anesthesia for children.
The FDA-cleared Hummingbird TTS is what parents want — pediatric ear tube placement that can be completed in-office without general anesthesia.
Traditional ear tube procedures can be extremely costly due to general anesthesia. With the Hummingbird, anesthesia and other associated costs are eliminated as the procedure is performed in-office.
FOX reports on how the Hummingbird device has transformed ear tube procedures for families in South Carolina.
Phoenix Children’s Hospital is one of the first hospitals in the nation to use a new device created to make ear tube procedures easier and quicker: the Hummingbird.
Meet Greg Mielke, Chief Commercial Officer for Preceptis Medical, and hear how his 19 years of medical device industry experience influences his life and work.
Published data shows the Hummingbird device is safe, successful, and well tolerated for ear tube placement in young children.
The Hummingbird device features an ergonomic design for more efficient ear tube delivery in children.
A downloadable brochure explains the Hummingbird procedure and associated costs.
The Hummingbird TTS procedure qualifies for HCPCS Code G0561, supporting safer in-office pediatric care.
The Hummingbird procedure places ear tubes in-office without general anesthesia, often at lower cost than traditional surgery.
The page compares Hummingbird ear tubes and Eustachian tube devices for safe, effective relief of children’s ear problems.
The Hummingbird TTS procedure places ear tubes without general anesthesia, using an ENT provider.
The company’s team developed the Hummingbird, an FDA-cleared device for in-office, minimally invasive ear tube placement.
Preceptis Medical Inc. products are protected by the following US Patent Numbers, which cover the Hummingbird Tympanostomy Tube System.
The Hummingbird procedure places ear tubes in-office without general anesthesia, typically within minutes.
Preceptis Medical appoints **Dave Carey** as Chief Executive Officer to drive the company’s strategic growth. The medical technology firm focuses on pediatric ENT care and is advancing its flagship **Hummingbird® Tympanostomy Tube System (TTS)** toward full market release. Carey’s leadership marks a key step in scaling the product’s commercialization efforts.
Jul 2025Yahoo FinanceNews article
Preceptis Medical expands FDA clearance for its Hummingbird Tympanostomy Tube System (TTS) to include office-based pediatric ear tube procedures in children as young as **six months**, broadening access beyond the prior 6–24-month age range. The system offers a less invasive alternative for treating ear infections in children. Preceptis specializes in surgical technologies aimed at reducing invasiveness for pediatric patients.
Aug 2022Hearing Health & Technology MattersNews article
Preceptis Medical receives FDA clearance for its Hummingbird tympanostomy tube system, enabling ENT surgeons to perform ear tube placements in-office for pediatric patients. The system streamlines a procedure previously requiring an operating room setting. The clearance expands access to a common treatment for chronic ear infections in children.
Jun 2020MassDeviceNews article
Preceptis Medical secures FDA 510(k) clearance for its **Hummingbird device**, enabling **ear tube placement in young children during ENT office visits without general anesthesia**. The clearance follows a **Pivotal Clinical Study**, marking a shift toward safer, anesthesia-free procedures for pediatric ear treatments.
Jun 2020PR NewswireNews article